Brandt J, Quaid K A, Folstein S E, Garber P, Maestri N E, Abbott M H, Slavney P R, Franz M L, Kasch L, Kazazian H H
Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
JAMA. 1989 Jun 2;261(21):3108-14.
Clinical medicine in the 21st century is almost certain to include wide-scale use of molecular genetic diagnostic tests. In September 1986, The Johns Hopkins University School of Medicine initiated a voluntary program of presymptomatic genetic testing for Huntington's disease for persons at 50% risk. DNA analyses using the D4S10 (G8), D4S43, and D4S95 locus probes have been performed for 55 people. Twelve of the tests have yielded positive results, 30 were negative, and 13 were uninformative. Initial reactions ranged from joy and relief to disappointment, sadness, and demoralization. Thus far, there have been no severe depressive reactions. Although the sample size is small, our data suggest that people who receive genetic test results cope well, at least over the short term, when the testing is performed in a clinical context that includes education, pretest counseling, psychological support, and regular follow-up.
21世纪的临床医学几乎肯定会广泛使用分子基因诊断测试。1986年9月,约翰·霍普金斯大学医学院针对有50%患病风险的人群启动了一项亨廷顿舞蹈症症状前基因检测的自愿项目。已对55人进行了使用D4S10(G8)、D4S43和D4S95位点探针的DNA分析。其中12项检测结果呈阳性,30项为阴性,13项结果无信息价值。最初的反应从喜悦、宽慰到失望、悲伤和士气低落不等。到目前为止,还没有出现严重的抑郁反应。尽管样本量较小,但我们的数据表明,在包括教育、检测前咨询、心理支持和定期随访的临床环境中进行检测时,接受基因检测结果的人至少在短期内应对良好。